Antibiotic Resistance Market Size, Share & Trends Report

Antibiotic Resistance Market Size, Share & Trends Analysis Report By Disease (cUTI, CDI), By Pathogen, By Drug Class, By Mechanism of Action, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-2-68038-663-9
  • Number of Pages: 120
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Market Segmentation

  • Antibiotic Resistance Disease Outlook (Revenue, USD Million, 2018 - 2030)
    • cUTI (Complicated Urinary Tract Infections)
    • CDI (Clostridioides difficile Infection)
    • ABSSSI (Acute bacterial skin and skin structure infections)
    • HABP (Hospital-acquired bacterial pneumonia)
    • CABP (Community-acquired pneumonia)
    • cIAI (Complicated intra-abdominal infection)
    • BSI (Bloodstream infection)
  • Antibiotic Resistance Pathogen Outlook (Revenue, USD Million, 2018 - 2030)
    • E. coli
    • K. pneumoniae
    • P. aeruginosa
    • S. aureus
    • A. baumannii
    • S. pneumoniae
    • H. influenzae
    • C. difficile
    • E. faecium
  • Antibiotic Resistance Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
    • Oxazolidinones
    • Lipoglycopeptides
    • Tetracyclines
    • Combination therapies
    • Cephalosporins
    • Others
  • Antibiotic Resistance Mechanism of Action Outlook (Revenue, USD Million, 2018 - 2030)
    • Protein Synthesis Inhibitors
    • Cell Wall Synthesis Inhibitors
    • RNA Synthesis Inhibitors
    • DNA Synthesis Inhibitors
    • Others
  • Antibiotic Resistance Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Antibiotic Resistance Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Antibiotic Resistance Market, By Disease
        • cUTI (Complicated Urinary Tract Infections)
        • CDI (Clostridioides difficile Infection)
        • ABSSSI (Acute bacterial skin and skin structure infections)
        • HABP (Hospital-acquired bacterial pneumonia)
        • CABP (Community-acquired pneumonia)
        • cIAI (Complicated intra-abdominal infection)
        • BSI (Bloodstream infection)
      • North America Antibiotic Resistance Market, By Pathogen
        • E. coli
        • K. pneumoniae
        • P. aeruginosa
        • S. aureus
        • A. baumannii
        • S. pneumoniae
        • H. influenzae
        • C. difficile
        • E. faecium
      • North America Antibiotic Resistance Market, By Drug Class
        • Oxazolidinones
        • Lipoglycopeptides
        • Tetracyclines
        • Combination therapies
        • Cephalosporins
        • Others
      • North America Antibiotic Resistance Market, By Mechanism of Action
        • Protein Synthesis Inhibitors
        • Cell Wall Synthesis Inhibitors
        • RNA Synthesis Inhibitors
        • DNA Synthesis Inhibitors
        • Others
      • North America Antibiotic Resistance Market, By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • U.S.
        • U.S. Antibiotic Resistance Market, By Disease
          • cUTI (Complicated Urinary Tract Infections)
          • CDI (Clostridioides difficile Infection)
          • ABSSSI (Acute bacterial skin and skin structure infections)
          • HABP (Hospital-acquired bacterial pneumonia)
          • CABP (Community-acquired pneumonia)
          • cIAI (Complicated intra-abdominal infection)
          • BSI (Bloodstream infection)
        • U.S. Antibiotic Resistance Market, By Pathogen
          • E. coli
          • K. pneumoniae
          • P. aeruginosa
          • S. aureus
          • A. baumannii
          • S. pneumoniae
          • H. influenzae
          • C. difficile
          • E. faecium
        • U.S. Antibiotic Resistance Market, By Drug Class
          • Oxazolidinones
          • Lipoglycopeptides
          • Tetracyclines
          • Combination therapies
          • Cephalosporins
          • Others
        • U.S. Antibiotic Resistance Market, By Mechanism of Action
          • Protein Synthesis Inhibitors
          • Cell Wall Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • Others
        • U.S. Antibiotic Resistance Market, By Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
      • Canada
        • Canada Antibiotic Resistance Market, By Disease
          • cUTI (Complicated Urinary Tract Infections)
          • CDI (Clostridioides difficile Infection)
          • ABSSSI (Acute bacterial skin and skin structure infections)
          • HABP (Hospital-acquired bacterial pneumonia)
          • CABP (Community-acquired pneumonia)
          • cIAI (Complicated intra-abdominal infection)
          • BSI (Bloodstream infection)
        • Canada Antibiotic Resistance Market, By Pathogen
          • E. coli
          • K. pneumoniae
          • P. aeruginosa
          • S. aureus
          • A. baumannii
          • S. pneumoniae
          • H. influenzae
          • C. difficile
          • E. faecium
        • Canada Antibiotic Resistance Market, By Drug Class
          • Oxazolidinones
          • Lipoglycopeptides
          • Tetracyclines
          • Combination therapies
          • Cephalosporins
          • Others
        • Canada Antibiotic Resistance Market, By Mechanism of Action
          • Protein Synthesis Inhibitors
          • Cell Wall Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • Others
        • Canada Antibiotic Resistance Market, By Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
    • Europe
      • Europe Antibiotic Resistance Market, By Disease
        • cUTI (Complicated Urinary Tract Infections)
        • CDI (Clostridioides difficile Infection)
        • ABSSSI (Acute bacterial skin and skin structure infections)
        • HABP (Hospital-acquired bacterial pneumonia)
        • CABP (Community-acquired pneumonia)
        • cIAI (Complicated intra-abdominal infection)
        • BSI (Bloodstream infection)
      • Europe Antibiotic Resistance Market, By Pathogen
        • E. coli
        • K. pneumoniae
        • P. aeruginosa
        • S. aureus
        • A. baumannii
        • S. pneumoniae
        • H. influenzae
        • C. difficile
        • E. faecium
      • Europe Antibiotic Resistance Market, By Drug Class
        • Oxazolidinones
        • Lipoglycopeptides
        • Tetracyclines
        • Combination therapies
        • Cephalosporins
        • Others
      • Europe Antibiotic Resistance Market, By Mechanism of Action
        • Protein Synthesis Inhibitors
        • Cell Wall Synthesis Inhibitors
        • RNA Synthesis Inhibitors
        • DNA Synthesis Inhibitors
        • Others
      • Europe Antibiotic Resistance Market, By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • UK
        • UK Antibiotic Resistance Market, By Disease
          • cUTI (Complicated Urinary Tract Infections)
          • CDI (Clostridioides difficile Infection)
          • ABSSSI (Acute bacterial skin and skin structure infections)
          • HABP (Hospital-acquired bacterial pneumonia)
          • CABP (Community-acquired pneumonia)
          • cIAI (Complicated intra-abdominal infection)
          • BSI (Bloodstream infection)
        • UK Antibiotic Resistance Market, By Pathogen
          • E. coli
          • K. pneumoniae
          • P. aeruginosa
          • S. aureus
          • A. baumannii
          • S. pneumoniae
          • H. influenzae
          • C. difficile
          • E. faecium
        • UK Antibiotic Resistance Market, By Drug Class
          • Oxazolidinones
          • Lipoglycopeptides
          • Tetracyclines
          • Combination therapies
          • Cephalosporins
          • Others
        • UK Antibiotic Resistance Market, By Mechanism of Action
          • Protein Synthesis Inhibitors
          • Cell Wall Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • Others
        • UK Antibiotic Resistance Market, By Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
      • Germany
        • Germany Antibiotic Resistance Market, By Disease
          • cUTI (Complicated Urinary Tract Infections)
          • CDI (Clostridioides difficile Infection)
          • ABSSSI (Acute bacterial skin and skin structure infections)
          • HABP (Hospital-acquired bacterial pneumonia)
          • CABP (Community-acquired pneumonia)
          • cIAI (Complicated intra-abdominal infection)
          • BSI (Bloodstream infection)
        • Germany Antibiotic Resistance Market, By Pathogen
          • E. coli
          • K. pneumoniae
          • P. aeruginosa
          • S. aureus
          • A. baumannii
          • S. pneumoniae
          • H. influenzae
          • C. difficile
          • E. faecium
        • Germany Antibiotic Resistance Market, By Drug Class
          • Oxazolidinones
          • Lipoglycopeptides
          • Tetracyclines
          • Combination therapies
          • Cephalosporins
          • Others
        • Germany Antibiotic Resistance Market, By Mechanism of Action
          • Protein Synthesis Inhibitors
          • Cell Wall Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • Others
        • Germany Antibiotic Resistance Market, By Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
      • France
        • France Antibiotic Resistance Market, By Disease
          • cUTI (Complicated Urinary Tract Infections)
          • CDI (Clostridioides difficile Infection)
          • ABSSSI (Acute bacterial skin and skin structure infections)
          • HABP (Hospital-acquired bacterial pneumonia)
          • CABP (Community-acquired pneumonia)
          • cIAI (Complicated intra-abdominal infection)
          • BSI (Bloodstream infection)
        • France Antibiotic Resistance Market, By Pathogen
          • E. coli
          • K. pneumoniae
          • P. aeruginosa
          • S. aureus
          • A. baumannii
          • S. pneumoniae
          • H. influenzae
          • C. difficile
          • E. faecium
        • France Antibiotic Resistance Market, By Drug Class
          • Oxazolidinones
          • Lipoglycopeptides
          • Tetracyclines
          • Combination therapies
          • Cephalosporins
          • Others
        • France Antibiotic Resistance Market, By Mechanism of Action
          • Protein Synthesis Inhibitors
          • Cell Wall Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • Others
        • France Antibiotic Resistance Market, By Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
      • Italy
        • Italy Antibiotic Resistance Market, By Disease
          • cUTI (Complicated Urinary Tract Infections)
          • CDI (Clostridioides difficile Infection)
          • ABSSSI (Acute bacterial skin and skin structure infections)
          • HABP (Hospital-acquired bacterial pneumonia)
          • CABP (Community-acquired pneumonia)
          • cIAI (Complicated intra-abdominal infection)
          • BSI (Bloodstream infection)
        • Italy Antibiotic Resistance Market, By Pathogen
          • E. coli
          • K. pneumoniae
          • P. aeruginosa
          • S. aureus
          • A. baumannii
          • S. pneumoniae
          • H. influenzae
          • C. difficile
          • E. faecium
        • Italy Antibiotic Resistance Market, By Drug Class
          • Oxazolidinones
          • Lipoglycopeptides
          • Tetracyclines
          • Combination therapies
          • Cephalosporins
          • Others
        • Italy Antibiotic Resistance Market, By Mechanism of Action
          • Protein Synthesis Inhibitors
          • Cell Wall Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • Others
        • Italy Antibiotic Resistance Market, By Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
      • Spain
        • Spain Antibiotic Resistance Market, By Disease
          • cUTI (Complicated Urinary Tract Infections)
          • CDI (Clostridioides difficile Infection)
          • ABSSSI (Acute bacterial skin and skin structure infections)
          • HABP (Hospital-acquired bacterial pneumonia)
          • CABP (Community-acquired pneumonia)
          • cIAI (Complicated intra-abdominal infection)
          • BSI (Bloodstream infection)
        • Spain Antibiotic Resistance Market, By Pathogen
          • E. coli
          • K. pneumoniae
          • P. aeruginosa
          • S. aureus
          • A. baumannii
          • S. pneumoniae
          • H. influenzae
          • C. difficile
          • E. faecium
        • Spain Antibiotic Resistance Market, By Drug Class
          • Oxazolidinones
          • Lipoglycopeptides
          • Tetracyclines
          • Combination therapies
          • Cephalosporins
          • Others
        • Spain Antibiotic Resistance Market, By Mechanism of Action
          • Protein Synthesis Inhibitors
          • Cell Wall Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • Others
        • Spain Antibiotic Resistance Market, By Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
      • Denmark
        • Denmark Antibiotic Resistance Market, By Disease
          • cUTI (Complicated Urinary Tract Infections)
          • CDI (Clostridioides difficile Infection)
          • ABSSSI (Acute bacterial skin and skin structure infections)
          • HABP (Hospital-acquired bacterial pneumonia)
          • CABP (Community-acquired pneumonia)
          • cIAI (Complicated intra-abdominal infection)
          • BSI (Bloodstream infection)
        • Denmark Antibiotic Resistance Market, By Pathogen
          • E. coli
          • K. pneumoniae
          • P. aeruginosa
          • S. aureus
          • A. baumannii
          • S. pneumoniae
          • H. influenzae
          • C. difficile
          • E. faecium
        • Denmark Antibiotic Resistance Market, By Drug Class
          • Oxazolidinones
          • Lipoglycopeptides
          • Tetracyclines
          • Combination therapies
          • Cephalosporins
          • Others
        • Denmark Antibiotic Resistance Market, By Mechanism of Action
          • Protein Synthesis Inhibitors
          • Cell Wall Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • Others
        • Denmark Antibiotic Resistance Market, By Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
      • Sweden
        • Sweden Antibiotic Resistance Market, By Disease
          • cUTI (Complicated Urinary Tract Infections)
          • CDI (Clostridioides difficile Infection)
          • ABSSSI (Acute bacterial skin and skin structure infections)
          • HABP (Hospital-acquired bacterial pneumonia)
          • CABP (Community-acquired pneumonia)
          • cIAI (Complicated intra-abdominal infection)
          • BSI (Bloodstream infection)
        • Sweden Antibiotic Resistance Market, By Pathogen
          • E. coli
          • K. pneumoniae
          • P. aeruginosa
          • S. aureus
          • A. baumannii
          • S. pneumoniae
          • H. influenzae
          • C. difficile
          • E. faecium
        • Sweden Antibiotic Resistance Market, By Drug Class
          • Oxazolidinones
          • Lipoglycopeptides
          • Tetracyclines
          • Combination therapies
          • Cephalosporins
          • Others
        • Sweden Antibiotic Resistance Market, By Mechanism of Action
          • Protein Synthesis Inhibitors
          • Cell Wall Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • Others
        • Sweden Antibiotic Resistance Market, By Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
      • Norway
        • Norway Antibiotic Resistance Market, By Disease
          • cUTI (Complicated Urinary Tract Infections)
          • CDI (Clostridioides difficile Infection)
          • ABSSSI (Acute bacterial skin and skin structure infections)
          • HABP (Hospital-acquired bacterial pneumonia)
          • CABP (Community-acquired pneumonia)
          • cIAI (Complicated intra-abdominal infection)
          • BSI (Bloodstream infection)
        • Norway Antibiotic Resistance Market, By Pathogen
          • E. coli
          • K. pneumoniae
          • P. aeruginosa
          • S. aureus
          • A. baumannii
          • S. pneumoniae
          • H. influenzae
          • C. difficile
          • E. faecium
        • Norway Antibiotic Resistance Market, By Drug Class
          • Oxazolidinones
          • Lipoglycopeptides
          • Tetracyclines
          • Combination therapies
          • Cephalosporins
          • Others
        • Norway Antibiotic Resistance Market, By Mechanism of Action
          • Protein Synthesis Inhibitors
          • Cell Wall Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • Others
        • Norway Antibiotic Resistance Market, By Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
    • Asia Pacific
      • Asia Pacific Antibiotic Resistance Market, By Disease
        • cUTI (Complicated Urinary Tract Infections)
        • CDI (Clostridioides difficile Infection)
        • ABSSSI (Acute bacterial skin and skin structure infections)
        • HABP (Hospital-acquired bacterial pneumonia)
        • CABP (Community-acquired pneumonia)
        • cIAI (Complicated intra-abdominal infection)
        • BSI (Bloodstream infection)
      • Asia Pacific Antibiotic Resistance Market, By Pathogen
        • E. coli
        • K. pneumoniae
        • P. aeruginosa
        • S. aureus
        • A. baumannii
        • S. pneumoniae
        • H. influenzae
        • C. difficile
        • E. faecium
      • Asia Pacific Antibiotic Resistance Market, By Drug Class
        • Oxazolidinones
        • Lipoglycopeptides
        • Tetracyclines
        • Combination therapies
        • Cephalosporins
        • Others
      • Asia Pacific Antibiotic Resistance Market, By Mechanism of Action
        • Protein Synthesis Inhibitors
        • Cell Wall Synthesis Inhibitors
        • RNA Synthesis Inhibitors
        • DNA Synthesis Inhibitors
        • Others
      • Asia Pacific Antibiotic Resistance Market, By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • China
        • China Antibiotic Resistance Market, By Disease
          • cUTI (Complicated Urinary Tract Infections)
          • CDI (Clostridioides difficile Infection)
          • ABSSSI (Acute bacterial skin and skin structure infections)
          • HABP (Hospital-acquired bacterial pneumonia)
          • CABP (Community-acquired pneumonia)
          • cIAI (Complicated intra-abdominal infection)
          • BSI (Bloodstream infection)
        • China Antibiotic Resistance Market, By Pathogen
          • E. coli
          • K. pneumoniae
          • P. aeruginosa
          • S. aureus
          • A. baumannii
          • S. pneumoniae
          • H. influenzae
          • C. difficile
          • E. faecium
        • China Antibiotic Resistance Market, By Drug Class
          • Oxazolidinones
          • Lipoglycopeptides
          • Tetracyclines
          • Combination therapies
          • Cephalosporins
          • Others
        • China Antibiotic Resistance Market, By Mechanism of Action
          • Protein Synthesis Inhibitors
          • Cell Wall Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • Others
        • China Antibiotic Resistance Market, By Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
      • Japan
        • Japan Antibiotic Resistance Market, By Disease
          • cUTI (Complicated Urinary Tract Infections)
          • CDI (Clostridioides difficile Infection)
          • ABSSSI (Acute bacterial skin and skin structure infections)
          • HABP (Hospital-acquired bacterial pneumonia)
          • CABP (Community-acquired pneumonia)
          • cIAI (Complicated intra-abdominal infection)
          • BSI (Bloodstream infection)
        • Japan Antibiotic Resistance Market, By Pathogen
          • E. coli
          • K. pneumoniae
          • P. aeruginosa
          • S. aureus
          • A. baumannii
          • S. pneumoniae
          • H. influenzae
          • C. difficile
          • E. faecium
        • Japan Antibiotic Resistance Market, By Drug Class
          • Oxazolidinones
          • Lipoglycopeptides
          • Tetracyclines
          • Combination therapies
          • Cephalosporins
          • Others
        • Japan Antibiotic Resistance Market, By Mechanism of Action
          • Protein Synthesis Inhibitors
          • Cell Wall Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • Others
        • Japan Antibiotic Resistance Market, By Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
      • India
        • India Antibiotic Resistance Market, By Disease
          • cUTI (Complicated Urinary Tract Infections)
          • CDI (Clostridioides difficile Infection)
          • ABSSSI (Acute bacterial skin and skin structure infections)
          • HABP (Hospital-acquired bacterial pneumonia)
          • CABP (Community-acquired pneumonia)
          • cIAI (Complicated intra-abdominal infection)
          • BSI (Bloodstream infection)
        • India Antibiotic Resistance Market, By Pathogen
          • E. coli
          • K. pneumoniae
          • P. aeruginosa
          • S. aureus
          • A. baumannii
          • S. pneumoniae
          • H. influenzae
          • C. difficile
          • E. faecium
        • India Antibiotic Resistance Market, By Drug Class
          • Oxazolidinones
          • Lipoglycopeptides
          • Tetracyclines
          • Combination therapies
          • Cephalosporins
          • Others
        • India Antibiotic Resistance Market, By Mechanism of Action
          • Protein Synthesis Inhibitors
          • Cell Wall Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • Others
        • India Antibiotic Resistance Market, By Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
      • Australia
        • Australia Antibiotic Resistance Market, By Disease
          • cUTI (Complicated Urinary Tract Infections)
          • CDI (Clostridioides difficile Infection)
          • ABSSSI (Acute bacterial skin and skin structure infections)
          • HABP (Hospital-acquired bacterial pneumonia)
          • CABP (Community-acquired pneumonia)
          • cIAI (Complicated intra-abdominal infection)
          • BSI (Bloodstream infection)
        • Australia Antibiotic Resistance Market, By Pathogen
          • E. coli
          • K. pneumoniae
          • P. aeruginosa
          • S. aureus
          • A. baumannii
          • S. pneumoniae
          • H. influenzae
          • C. difficile
          • E. faecium
        • Australia Antibiotic Resistance Market, By Drug Class
          • Oxazolidinones
          • Lipoglycopeptides
          • Tetracyclines
          • Combination therapies
          • Cephalosporins
          • Others
        • Australia Antibiotic Resistance Market, By Mechanism of Action
          • Protein Synthesis Inhibitors
          • Cell Wall Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • Others
        • Australia Antibiotic Resistance Market, By Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
      • Thailand
        • Thailand Antibiotic Resistance Market, By Disease
          • cUTI (Complicated Urinary Tract Infections)
          • CDI (Clostridioides difficile Infection)
          • ABSSSI (Acute bacterial skin and skin structure infections)
          • HABP (Hospital-acquired bacterial pneumonia)
          • CABP (Community-acquired pneumonia)
          • cIAI (Complicated intra-abdominal infection)
          • BSI (Bloodstream infection)
        • Thailand Antibiotic Resistance Market, By Pathogen
          • E. coli
          • K. pneumoniae
          • P. aeruginosa
          • S. aureus
          • A. baumannii
          • S. pneumoniae
          • H. influenzae
          • C. difficile
          • E. faecium
        • Thailand Antibiotic Resistance Market, By Drug Class
          • Oxazolidinones
          • Lipoglycopeptides
          • Tetracyclines
          • Combination therapies
          • Cephalosporins
          • Others
        • Thailand Antibiotic Resistance Market, By Mechanism of Action
          • Protein Synthesis Inhibitors
          • Cell Wall Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • Others
        • Thailand Antibiotic Resistance Market, By Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
      • South Korea
        • South Korea Antibiotic Resistance Market, By Disease
          • cUTI (Complicated Urinary Tract Infections)
          • CDI (Clostridioides difficile Infection)
          • ABSSSI (Acute bacterial skin and skin structure infections)
          • HABP (Hospital-acquired bacterial pneumonia)
          • CABP (Community-acquired pneumonia)
          • cIAI (Complicated intra-abdominal infection)
          • BSI (Bloodstream infection)
        • South Korea Antibiotic Resistance Market, By Pathogen
          • E. coli
          • K. pneumoniae
          • P. aeruginosa
          • S. aureus
          • A. baumannii
          • S. pneumoniae
          • H. influenzae
          • C. difficile
          • E. faecium
        • South Korea Antibiotic Resistance Market, By Drug Class
          • Oxazolidinones
          • Lipoglycopeptides
          • Tetracyclines
          • Combination therapies
          • Cephalosporins
          • Others
        • South Korea Antibiotic Resistance Market, By Mechanism of Action
          • Protein Synthesis Inhibitors
          • Cell Wall Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • Others
        • South Korea Antibiotic Resistance Market, By Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
    • Latin America
      • Latin America Antibiotic Resistance Market, By Disease
        • cUTI (Complicated Urinary Tract Infections)
        • CDI (Clostridioides difficile Infection)
        • ABSSSI (Acute bacterial skin and skin structure infections)
        • HABP (Hospital-acquired bacterial pneumonia)
        • CABP (Community-acquired pneumonia)
        • cIAI (Complicated intra-abdominal infection)
        • BSI (Bloodstream infection)
      • Latin America Antibiotic Resistance Market, By Pathogen
        • E. coli
        • K. pneumoniae
        • P. aeruginosa
        • S. aureus
        • A. baumannii
        • S. pneumoniae
        • H. influenzae
        • C. difficile
        • E. faecium
      • Latin America Antibiotic Resistance Market, By Drug Class
        • Oxazolidinones
        • Lipoglycopeptides
        • Tetracyclines
        • Combination therapies
        • Cephalosporins
        • Others
      • Latin America Antibiotic Resistance Market, By Mechanism of Action
        • Protein Synthesis Inhibitors
        • Cell Wall Synthesis Inhibitors
        • RNA Synthesis Inhibitors
        • DNA Synthesis Inhibitors
        • Others
      • Latin America Antibiotic Resistance Market, By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • Brazil
        • Brazil Antibiotic Resistance Market, By Disease
          • cUTI (Complicated Urinary Tract Infections)
          • CDI (Clostridioides difficile Infection)
          • ABSSSI (Acute bacterial skin and skin structure infections)
          • HABP (Hospital-acquired bacterial pneumonia)
          • CABP (Community-acquired pneumonia)
          • cIAI (Complicated intra-abdominal infection)
          • BSI (Bloodstream infection)
        • Brazil Antibiotic Resistance Market, By Pathogen
          • E. coli
          • K. pneumoniae
          • P. aeruginosa
          • S. aureus
          • A. baumannii
          • S. pneumoniae
          • H. influenzae
          • C. difficile
          • E. faecium
        • Brazil Antibiotic Resistance Market, By Drug Class
          • Oxazolidinones
          • Lipoglycopeptides
          • Tetracyclines
          • Combination therapies
          • Cephalosporins
          • Others
        • Brazil Antibiotic Resistance Market, By Mechanism of Action
          • Protein Synthesis Inhibitors
          • Cell Wall Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • Others
        • Brazil Antibiotic Resistance Market, By Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
      • Mexico
        • Mexico Antibiotic Resistance Market, By Disease
          • cUTI (Complicated Urinary Tract Infections)
          • CDI (Clostridioides difficile Infection)
          • ABSSSI (Acute bacterial skin and skin structure infections)
          • HABP (Hospital-acquired bacterial pneumonia)
          • CABP (Community-acquired pneumonia)
          • cIAI (Complicated intra-abdominal infection)
          • BSI (Bloodstream infection)
        • Mexico Antibiotic Resistance Market, By Pathogen
          • E. coli
          • K. pneumoniae
          • P. aeruginosa
          • S. aureus
          • A. baumannii
          • S. pneumoniae
          • H. influenzae
          • C. difficile
          • E. faecium
        • Mexico Antibiotic Resistance Market, By Drug Class
          • Oxazolidinones
          • Lipoglycopeptides
          • Tetracyclines
          • Combination therapies
          • Cephalosporins
          • Others
        • Mexico Antibiotic Resistance Market, By Mechanism of Action
          • Protein Synthesis Inhibitors
          • Cell Wall Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • Others
        • Mexico Antibiotic Resistance Market, By Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
      • Argentina
        • Argentina Antibiotic Resistance Market, By Disease
          • cUTI (Complicated Urinary Tract Infections)
          • CDI (Clostridioides difficile Infection)
          • ABSSSI (Acute bacterial skin and skin structure infections)
          • HABP (Hospital-acquired bacterial pneumonia)
          • CABP (Community-acquired pneumonia)
          • cIAI (Complicated intra-abdominal infection)
          • BSI (Bloodstream infection)
        • Argentina Antibiotic Resistance Market, By Pathogen
          • E. coli
          • K. pneumoniae
          • P. aeruginosa
          • S. aureus
          • A. baumannii
          • S. pneumoniae
          • H. influenzae
          • C. difficile
          • E. faecium
        • Argentina Antibiotic Resistance Market, By Drug Class
          • Oxazolidinones
          • Lipoglycopeptides
          • Tetracyclines
          • Combination therapies
          • Cephalosporins
          • Others
        • Argentina Antibiotic Resistance Market, By Mechanism of Action
          • Protein Synthesis Inhibitors
          • Cell Wall Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • Others
        • Argentina Antibiotic Resistance Market, By Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
    • Middle East & Africa
      • Middle East & Africa Antibiotic Resistance Market, By Disease
        • cUTI (Complicated Urinary Tract Infections)
        • CDI (Clostridioides difficile Infection)
        • ABSSSI (Acute bacterial skin and skin structure infections)
        • HABP (Hospital-acquired bacterial pneumonia)
        • CABP (Community-acquired pneumonia)
        • cIAI (Complicated intra-abdominal infection)
        • BSI (Bloodstream infection)
      • Middle East & Africa Antibiotic Resistance Market, By Pathogen
        • E. coli
        • K. pneumoniae
        • P. aeruginosa
        • S. aureus
        • A. baumannii
        • S. pneumoniae
        • H. influenzae
        • C. difficile
        • E. faecium
      • Middle East & Africa Antibiotic Resistance Market, By Drug Class
        • Oxazolidinones
        • Lipoglycopeptides
        • Tetracyclines
        • Combination therapies
        • Cephalosporins
        • Others
      • Middle East & Africa Antibiotic Resistance Market, By Mechanism of Action
        • Protein Synthesis Inhibitors
        • Cell Wall Synthesis Inhibitors
        • RNA Synthesis Inhibitors
        • DNA Synthesis Inhibitors
        • Others
      • Middle East & Africa Antibiotic Resistance Market, By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • South Africa
        • South Africa Antibiotic Resistance Market, By Disease
          • cUTI (Complicated Urinary Tract Infections)
          • CDI (Clostridioides difficile Infection)
          • ABSSSI (Acute bacterial skin and skin structure infections)
          • HABP (Hospital-acquired bacterial pneumonia)
          • CABP (Community-acquired pneumonia)
          • cIAI (Complicated intra-abdominal infection)
          • BSI (Bloodstream infection)
        • South Africa Antibiotic Resistance Market, By Pathogen
          • E. coli
          • K. pneumoniae
          • P. aeruginosa
          • S. aureus
          • A. baumannii
          • S. pneumoniae
          • H. influenzae
          • C. difficile
          • E. faecium
        • South Africa Antibiotic Resistance Market, By Drug Class
          • Oxazolidinones
          • Lipoglycopeptides
          • Tetracyclines
          • Combination therapies
          • Cephalosporins
          • Others
        • South Africa Antibiotic Resistance Market, By Mechanism of Action
          • Protein Synthesis Inhibitors
          • Cell Wall Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • Others
        • South Africa Antibiotic Resistance Market, By Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
      • Saudi Arabia
        • Saudi Arabia Antibiotic Resistance Market, By Disease
          • cUTI (Complicated Urinary Tract Infections)
          • CDI (Clostridioides difficile Infection)
          • ABSSSI (Acute bacterial skin and skin structure infections)
          • HABP (Hospital-acquired bacterial pneumonia)
          • CABP (Community-acquired pneumonia)
          • cIAI (Complicated intra-abdominal infection)
          • BSI (Bloodstream infection)
        • Saudi Arabia Antibiotic Resistance Market, By Pathogen
          • E. coli
          • K. pneumoniae
          • P. aeruginosa
          • S. aureus
          • A. baumannii
          • S. pneumoniae
          • H. influenzae
          • C. difficile
          • E. faecium
        • Saudi Arabia Antibiotic Resistance Market, By Drug Class
          • Oxazolidinones
          • Lipoglycopeptides
          • Tetracyclines
          • Combination therapies
          • Cephalosporins
          • Others
        • Saudi Arabia Antibiotic Resistance Market, By Mechanism of Action
          • Protein Synthesis Inhibitors
          • Cell Wall Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • Others
        • Saudi Arabia Antibiotic Resistance Market, By Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
      • UAE
        • UAE Antibiotic Resistance Market, By Disease
          • cUTI (Complicated Urinary Tract Infections)
          • CDI (Clostridioides difficile Infection)
          • ABSSSI (Acute bacterial skin and skin structure infections)
          • HABP (Hospital-acquired bacterial pneumonia)
          • CABP (Community-acquired pneumonia)
          • cIAI (Complicated intra-abdominal infection)
          • BSI (Bloodstream infection)
        • UAE Antibiotic Resistance Market, By Pathogen
          • E. coli
          • K. pneumoniae
          • P. aeruginosa
          • S. aureus
          • A. baumannii
          • S. pneumoniae
          • H. influenzae
          • C. difficile
          • E. faecium
        • UAE Antibiotic Resistance Market, By Drug Class
          • Oxazolidinones
          • Lipoglycopeptides
          • Tetracyclines
          • Combination therapies
          • Cephalosporins
          • Others
        • UAE Antibiotic Resistance Market, By Mechanism of Action
          • Protein Synthesis Inhibitors
          • Cell Wall Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • Others
        • UAE Antibiotic Resistance Market, By Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
      • Kuwait
        • Kuwait Antibiotic Resistance Market, By Disease
          • cUTI (Complicated Urinary Tract Infections)
          • CDI (Clostridioides difficile Infection)
          • ABSSSI (Acute bacterial skin and skin structure infections)
          • HABP (Hospital-acquired bacterial pneumonia)
          • CABP (Community-acquired pneumonia)
          • cIAI (Complicated intra-abdominal infection)
          • BSI (Bloodstream infection)
        • Kuwait Antibiotic Resistance Market, By Pathogen
          • E. coli
          • K. pneumoniae
          • P. aeruginosa
          • S. aureus
          • A. baumannii
          • S. pneumoniae
          • H. influenzae
          • C. difficile
          • E. faecium
        • Kuwait Antibiotic Resistance Market, By Drug Class
          • Oxazolidinones
          • Lipoglycopeptides
          • Tetracyclines
          • Combination therapies
          • Cephalosporins
          • Others
        • Kuwait Antibiotic Resistance Market, By Mechanism of Action
          • Protein Synthesis Inhibitors
          • Cell Wall Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • Others
        • Kuwait Antibiotic Resistance Market, By Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon